Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Allan CamaisaDirector | Calidi BiotherapeuticsCLDI | Open-market sale | 25/12/12 | 25/12/16 | 850 sh | $1.46 | $1,241 | −1.1% |
Eric E. PomaCEO | Calidi BiotherapeuticsCLDI | Open-market buy | 25/08/21 | 25/08/25 | 25,000 sh | $2.00 | $50,000 | No record |
James A. SchoeneckDirector | Calidi BiotherapeuticsCLDI | Open-market buy | 25/08/21 | 25/08/25 | 75,000 sh | $2.00 | $150,000 | +6613.8% |
Calidi BiotherapeuticsCLDI | Open-market buy | 25/08/21 | 25/08/25 | 2,500 sh | $2.00 | $5,000 | No record | |
Scott LeftwichDirector | Calidi BiotherapeuticsCLDI | Open-market buy | 25/08/21 | 25/08/25 | 125,000 sh | $2.00 | $250,000 | +2212.4% |
Allan CamaisaCEO and Chairman | Calidi BiotherapeuticsCLDI | Open-market sale | 24/12/17 | 24/12/18 | 10,000 sh | $1.62 | $16,200 | −13.0% |